Signaturefd LLC raised its stake in The Clorox Company (NYSE:CLX – Free Report) by 44.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 20,395 shares of the company’s stock after purchasing an additional 6,279 shares during the quarter. Signaturefd LLC’s holdings in Clorox were worth $1,796,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Clorox in the second quarter worth approximately $958,640,000. Bank of America Corp DE bought a new stake in Clorox during the 2nd quarter valued at $179,780,000. Royal Bank of Canada raised its holdings in Clorox by 20.1% during the 1st quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock valued at $146,969,000 after buying an additional 237,301 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in Clorox during the 2nd quarter valued at $123,154,000. Finally, Confluence Investment Management LLC boosted its position in Clorox by 33.8% during the 2nd quarter. Confluence Investment Management LLC now owns 1,247,644 shares of the company’s stock valued at $119,075,000 after buying an additional 315,069 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Price Performance
Shares of Clorox stock opened at $86.78 on Tuesday. The business has a 50 day moving average of $90.49 and a 200 day moving average of $100.42. The Clorox Company has a 52 week low of $79.12 and a 52 week high of $128.90. The company has a market cap of $10.50 billion, a PE ratio of 18.00, a P/E/G ratio of 2.89 and a beta of 0.59. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The firm’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities research analysts forecast that The Clorox Company will post 5.66 earnings per share for the current year.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 5.8%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is currently 103.73%.
Wall Street Analyst Weigh In
CLX has been the topic of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of Clorox from $90.00 to $85.00 and set an “equal weight” rating on the stock in a report on Monday, October 5th. Wall Street Zen downgraded shares of Clorox from a “hold” rating to a “sell” rating in a research note on Saturday, October 3rd. UBS Group set a $91.00 target price on shares of Clorox in a report on Thursday, October 15th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research note on Monday, September 14th. Finally, Barclays reduced their price target on Clorox from $84.00 to $80.00 and set an “underweight” rating on the stock in a report on Friday, October 16th. Twelve analysts have rated the stock with a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $93.57.
Check Out Our Latest Research Report on CLX
About Clorox
The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.
Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.
Further Reading
- Five stocks we like better than Clorox
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
